B
Bodu Liu
Researcher at Cold Spring Harbor Laboratory
Publications - 25
Citations - 2842
Bodu Liu is an academic researcher from Cold Spring Harbor Laboratory. The author has contributed to research in topics: Metastasis & Breast cancer. The author has an hindex of 18, co-authored 24 publications receiving 2335 citations. Previous affiliations of Bodu Liu include Sun Yat-sen University.
Papers
More filters
Journal ArticleDOI
A Cytoplasmic NF-κB Interacting Long Noncoding RNA Blocks IκB Phosphorylation and Suppresses Breast Cancer Metastasis
Bodu Liu,Lijuan Sun,Qiang Liu,Chang Gong,Yandan Yao,Xiao-Bin Lv,Ling Lin,Herui Yao,Fengxi Su,Dangsheng Li,Mu Sheng Zeng,Erwei Song +11 more
TL;DR: This work identifies an NF-KappaB Interacting LncRNA (NKILA), which is upregulated by NF-κB, binds to NF-σκB/IκBs, and directly masks phosphorylation motifs of IKKB, thereby inhibiting IKK-induced IκBosphorylation and NF-kkB activation.
Journal ArticleDOI
CCL18 from Tumor-Associated Macrophages Promotes Breast Cancer Metastasis via PITPNM3
Jingqi Chen,Jingqi Chen,Yandan Yao,Chang Gong,Fengyan Yu,Shicheng Su,Jianing Chen,Bodu Liu,Hui Deng,Fengsong Wang,Ling Lin,Herui Yao,Fengxi Su,Karen S. Anderson,Qiang Liu,Qiang Liu,Mark E. Ewen,Xuebiao Yao,Erwei Song +18 more
TL;DR: In this article, the authors show that breast TAMs abundantly produce CCL18, and its expression in blood or cancer stroma is associated with metastasis and reduced patient survival.
Journal ArticleDOI
Up-regulation of miR-21 mediates resistance to trastuzumab therapy for breast cancer.
TL;DR: It is demonstrated that miR-21 expression was up-regulated and its function was elevated in HER2+ BT474, SKBR3, and MDA-MB-453 breast cancer cells that are induced to acquire trastuzumab resistance by long-term exposure to the antibody, whereas protein expression of the PTEN gene, a miR -21 target, was reduced.
Journal ArticleDOI
MiR-200b and miR-15b regulate chemotherapy-induced epithelial-mesenchymal transition in human tongue cancer cells by targeting BMI1
Lijuan Sun,Y. Yao,Bodu Liu,Zhong-Ning Lin,Ling Lin,Meisongzhu Yang,W. M. Zhang,Wen Hui Chen,C. Pan,Qiang Liu,Erwei Song,Erwei Song,Jiexin Li +12 more
TL;DR: Stable chemotherapy-resistant tongue squamous cell carcinoma cell lines are established by exposing the parental CAL27 and SCC25 lines to escalating concentrations of cisplatin for 6 months and it is suggested that reduced expression of miR-200b and miB-15b underscores the mechanisms of chemotherapy-induced EMT in TSCC, and may serve as therapeutic targets to reverse chemotherapy resistance in tongue cancers.
Journal ArticleDOI
MicroRNAs and cancer: Key paradigms in molecular therapy (Review)
TL;DR: The present study reviews the studies and examines the roles of miRNAs in cancer diagnosis, prognosis and treatment, and discusses the potential therapeutic modality of exploiting mi RNAs.